What this means
Inferior alveolar nerve (IAN) injury represents a substantial complication in oral and maxillofacial surgery, often leading to persistent neurosensory dysregulation with limited effective treatment options. This narrative review analyzes the biological rationale for regenerative peptides as potential adjuncts in peripheral nerve repair and presents three hypothesis-generating clinical cases managed using a multimodal approach.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Not stated
- Kind of research
- A study
The science
- Original title
- Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases.
- Authors
- Froum S, Estrin N, Pico G et al.
- Journal
- Frontiers in oral health
- Published
- Oct 15, 2026
- Study type
- Study
- PMID
- 42876687 ↗
Abstract
Inferior alveolar nerve (IAN) injury represents a substantial complication in oral and maxillofacial surgery, often leading to persistent neurosensory dysregulation with limited effective treatment options. This narrative review analyzes the biological rationale for regenerative peptides as potential adjuncts in peripheral nerve repair and presents three hypothesis-generating clinical cases managed using a multimodal approach. Experimental evidence suggests that peptides, such as BPC-157, thymosin β4 derivatives (TB-500), and ARA-290, may affect biological pathways implicated in peripheral nerve repair, such as inflammation regulation, cytoprotection, angiogenic signaling, extracellular matrix remodeling, Schwann cell biology, and axonal regeneration. Nonetheless, these processes have been demonstrated mainly in preclinical models and have not been directly established in patients with IAN injury. Three illustrative clinical cases treated with a multimodal method incorporating peptide agents, dexamethasone, and local anesthetic showed neurosensory recovery during follow-up. Nonetheless, owing to the uncontrolled nature of these observations, spontaneous recovery and other confounding factors cannot be excluded, and causality cannot be established. Consequently, a phase-based intervention framework is proposed, emphasizing a biologically informed phase-mediated management system. Despite promising biological rationale, peptide-based interventions remain investigational, with unresolved questions concerning safety, delivery, optimal dosing, and long-term outcomes. Rigorous, controlled clinical trials and standardized outcome measures are required to validate efficacy and define their role with contemporary management paradigms for IAN injury.
Froum S, Estrin N, Pico G et al. Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases. Frontiers in oral health. 2026. doi:10.3389/froh.2026.1907109. PMID: 42876687. https://pubmed.ncbi.nlm.nih.gov/42876687/
Related research
Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome.
BACKGROUND: Diabetic foot syndrome (DFS) is characterized by chronic inflammation, thrombotic imbalance, and impaired wound healing, yet systemic molecular alterations underlying this complication remain incompletely…
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
A modified form of thymosin beta 4 helped heart tissue after heart attack in animals
Researchers changed a protein so it stays in the body longer and tested it for heart attack damage. This study was done in animals, so it does not show the same effect in people.
See all research on BPC-157 peptide →